ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd.

SSE:603976.SS

17.35 (CNY) • At close May 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013
Revenue 801.122900.649796.198796.657501.982521.081595.781508.682469.995479.684436.034405.802
Cost of Revenue 635.482759.022629.406592.015373.723379.669424.982347.674319.847349.126302.786290.357
Gross Profit 165.64141.627166.792204.642128.258141.411170.799161.008150.148130.558133.248115.445
Gross Profit Ratio 0.2070.1570.2090.2570.2560.2710.2870.3170.3190.2720.3060.284
Reseach & Development Expenses 20.2623.42919.1112.0788.2545.2732.8990.03120.7824.31816.3080
General & Administrative Expenses 11.8039.7537.43410.9378.70210.22212.20311.72513.0529.5028.12325.123
Selling & Marketing Expenses 8.65513.60615.13217.96731.3133.6535.90930.46928.05725.63524.59426.056
SG&A 20.45823.35922.56628.90340.01243.87248.11242.19441.10935.13732.71751.179
Other Expenses 59.60149.96839.86134.81327.44532.452-0.0890.2184.4262.4423.4281.765
Operating Expenses 100.31996.75681.53775.79475.71181.59785.73365.71868.45361.59658.05454.72
Operating Income 65.3244.87193.255122.63961.88971.89194.09796.73279.2568.22976.52661.806
Operating Income Ratio 0.0820.050.1170.1540.1230.1380.1580.190.1690.1420.1760.152
Total Other Income Expenses Net -5.111-0.044-34.7053.334-0.513-0.545-0.0890.2183.8131.3913.281.163
Income Before Tax 60.20944.82758.55125.97361.37671.34694.00896.9583.06669.6279.80662.969
Income Before Tax Ratio 0.0750.050.0740.1580.1220.1370.1580.1910.1770.1450.1830.155
Income Tax Expense 6.9614.559-6.21519.3698.32610.28911.24114.77212.5548.92110.8928.23
Net Income 53.24940.26864.771106.60453.0561.05782.76782.17870.51160.69968.91354.739
Net Income Ratio 0.0660.0450.0810.1340.1060.1170.1390.1620.150.1270.1580.135
EPS 0.350.270.430.710.350.40.550.650.620.540.610.49
EPS Diluted 0.350.270.430.710.350.40.550.650.620.540.610.49
EBITDA 197.063173.198165.793206.7116.439111.176142.084139.174113.89796.79102.79760.725
EBITDA Ratio 0.2460.1920.2080.2590.2320.2130.2380.2740.2420.2020.2360.15